Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Cytokine network: new targeted therapy for pancreatic cancer.

Matsuo Y, Takeyama H, Guha S.

Curr Pharm Des. 2012;18(17):2416-9. Review.

PMID:
22372505
[PubMed - indexed for MEDLINE]
2.

Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Li X, Ma Q, Xu Q, Duan W, Lei J, Wu E.

Curr Pharm Des. 2012;18(17):2404-15. Review.

PMID:
22372501
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.

Gacche RN, Meshram RJ.

Prog Biophys Mol Biol. 2013 Nov;113(2):333-54. doi: 10.1016/j.pbiomolbio.2013.10.001. Epub 2013 Oct 15. Review.

PMID:
24139944
[PubMed - indexed for MEDLINE]
4.

Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer.

Aikawa T, Gunn J, Spong SM, Klaus SJ, Korc M.

Mol Cancer Ther. 2006 May;5(5):1108-16.

PMID:
16731742
[PubMed - indexed for MEDLINE]
Free Article
5.

Interventions that induce modifications in the tumor microenvironment.

Bernhard EJ.

Cancer Radiother. 2011 Aug;15(5):376-82. doi: 10.1016/j.canrad.2011.01.007. Epub 2011 May 14. Review.

PMID:
21571567
[PubMed - indexed for MEDLINE]
6.

Molecular mechanisms of pancreatic cancer dissemination: the role of the chemokine system.

Marchesi F, Grizzi F, Laghi L, Mantovani A, Allavena P.

Curr Pharm Des. 2012;18(17):2432-8. Review.

PMID:
22372498
[PubMed - indexed for MEDLINE]
7.

Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer.

Taeger J, Moser C, Hellerbrand C, Mycielska ME, Glockzin G, Schlitt HJ, Geissler EK, Stoeltzing O, Lang SA.

Mol Cancer Ther. 2011 Nov;10(11):2157-67. doi: 10.1158/1535-7163.MCT-11-0312. Epub 2011 Sep 1.

PMID:
21885862
[PubMed - indexed for MEDLINE]
Free Article
8.

Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.

Cui J, Jiang W, Wang S, Wang L, Xie K.

Curr Pharm Des. 2012;18(17):2464-71. Review.

PMID:
22372504
[PubMed - indexed for MEDLINE]
9.

Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.

Pietras K, Pahler J, Bergers G, Hanahan D.

PLoS Med. 2008 Jan 29;5(1):e19. doi: 10.1371/journal.pmed.0050019.

PMID:
18232728
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.

Tomioka D, Maehara N, Kuba K, Mizumoto K, Tanaka M, Matsumoto K, Nakamura T.

Cancer Res. 2001 Oct 15;61(20):7518-24.

PMID:
11606388
[PubMed - indexed for MEDLINE]
Free Article
11.

Hypoxia and angiogenesis in pancreatic cancer.

Garcea G, Doucas H, Steward WP, Dennison AR, Berry DP.

ANZ J Surg. 2006 Sep;76(9):830-42. Review.

PMID:
16922908
[PubMed - indexed for MEDLINE]
12.

Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.

Wente MN, Keane MP, Burdick MD, Friess H, Büchler MW, Ceyhan GO, Reber HA, Strieter RM, Hines OJ.

Cancer Lett. 2006 Sep 28;241(2):221-7. Epub 2006 Feb 3.

PMID:
16458421
[PubMed - indexed for MEDLINE]
13.

Defining new paradigms for the treatment of pancreatic cancer.

Almhanna K, Philip PA.

Curr Treat Options Oncol. 2011 Jun;12(2):111-25. doi: 10.1007/s11864-011-0150-8. Review.

PMID:
21461670
[PubMed - indexed for MEDLINE]
14.

Pancreatic cancer: from molecular signature to target therapy.

Longo R, Cacciamani F, Naso G, Gasparini G.

Crit Rev Oncol Hematol. 2008 Dec;68(3):197-211. doi: 10.1016/j.critrevonc.2008.03.003. Epub 2008 Apr 23. Review.

PMID:
18436450
[PubMed - indexed for MEDLINE]
15.

Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis.

Ishikawa T, Chen J, Wang J, Okada F, Sugiyama T, Kobayashi T, Shindo M, Higashino F, Katoh H, Asaka M, Kondo T, Hosokawa M, Kobayashi M.

Oncogene. 2003 Feb 27;22(8):1238-42.

PMID:
12606950
[PubMed - indexed for MEDLINE]
16.

Bone marrow-derived proangiogenic cells in pancreatic cancer.

Mizukami Y.

J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:23-6. doi: 10.1111/j.1440-1746.2011.07012.x. Review.

PMID:
22320912
[PubMed - indexed for MEDLINE]
17.

Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content.

McCarty MF, Somcio RJ, Stoeltzing O, Wey J, Fan F, Liu W, Bucana C, Ellis LM.

J Clin Invest. 2007 Aug;117(8):2114-22.

PMID:
17641778
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Biological aspects of angiogenesis in multiple myeloma.

Otjacques E, Binsfeld M, Noel A, Beguin Y, Cataldo D, Caers J.

Int J Hematol. 2011 Dec;94(6):505-18. doi: 10.1007/s12185-011-0963-z. Epub 2011 Nov 17. Review.

PMID:
22086206
[PubMed - indexed for MEDLINE]
19.

Consequences of angiogenesis for tumor progression, metastasis and cancer therapy.

Rak JW, St Croix BD, Kerbel RS.

Anticancer Drugs. 1995 Feb;6(1):3-18. Review.

PMID:
7538829
[PubMed - indexed for MEDLINE]
20.

Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond.

Mittal K, Ebos J, Rini B.

Semin Oncol. 2014 Apr;41(2):235-51. doi: 10.1053/j.seminoncol.2014.02.007. Epub 2014 Feb 28. Review.

PMID:
24787295
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk